Format

Send to

Choose Destination
Sci Transl Med. 2014 Apr 16;6(232):232fs16. doi: 10.1126/scitranslmed.3008558.

Manufacturing challenges in regenerative medicine.

Author information

1
Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.

Abstract

Along with scientific and regulatory issues, the translation of cell and tissue therapies in the routine clinical practice needs to address standardization and cost-effectiveness through the definition of suitable manufacturing paradigms.

PMID:
24739757
DOI:
10.1126/scitranslmed.3008558
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center